Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
0.9869
-0.0331 (-3.25%)
At close: Dec 5, 2025, 4:00 PM EST
0.9948
+0.0079 (0.80%)
After-hours: Dec 5, 2025, 5:18 PM EST
Rockwell Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Rockwell Medical stock has a target of 2.50, which predicts a 153.32% increase from the current stock price of 0.99.
Price Target: $2.50 (+153.32%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Rockwell Medical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $2.5 | Strong Buy | Maintains | $3 → $2.5 | +153.32% | Nov 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $3 | Strong Buy | Maintains | $7 → $3 | +203.98% | Mar 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +609.29% | Dec 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +609.29% | Nov 25, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +406.64% | Nov 14, 2024 |
Financial Forecast
Revenue This Year
68.81M
from 101.49M
Decreased by -32.20%
Revenue Next Year
74.40M
from 68.81M
Increased by 8.12%
EPS This Year
-0.18
from -0.03
EPS Next Year
-0.11
from -0.18
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 71.2M | 79.5M | |
| Avg | 68.8M | 74.4M | |
| Low | 65.7M | 68.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -29.8% | 15.5% | |
| Avg | -32.2% | 8.1% | |
| Low | -35.2% | -0.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.18 | -0.07 | |
| Avg | -0.18 | -0.11 | |
| Low | -0.18 | -0.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.